| PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma MR Migden, D Rischin, CD Schmults, A Guminski, A Hauschild, KD Lewis, ... New England Journal of Medicine 379 (4), 341-351, 2018 | 1265 | 2018 |
| Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry J Mazieres, A Drilon, A Lusque, L Mhanna, AB Cortot, L Mezquita, ... Annals of Oncology 30 (8), 1321-1328, 2019 | 1019 | 2019 |
| Prognostic Significance of PD-L1+ and CD8+ Immune Cells in HPV+ Oropharyngeal Squamous Cell Carcinoma B Solomon, RJ Young, M Bressel, D Urban, S Hendry, A Thai, C Angel, ... Cancer immunology research 6 (3), 295-304, 2018 | 119 | 2018 |
| Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis D Rischin, NI Khushalani, CD Schmults, A Guminski, ALS Chang, ... Journal for immunotherapy of cancer 9 (8), 2021 | 64 | 2021 |
| Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations (ImmunoTarget). J Mazieres, AE Drilon, L Mhanna, J Milia, A Lusque, AB Cortot, ... Journal of Clinical Oncology 36 (15_suppl), 9010-9010, 2018 | 61 | 2018 |
| CAPTEM in metastatic well-differentiated intermediate to high grade neuroendocrine tumors: a single centre experience A Sahu, M Jefford, J Lai-Kwon, A Thai, RJ Hicks, M Michael Journal of Oncology 2019, 2019 | 43 | 2019 |
| Treatment of ALK-positive nonsmall cell lung cancer: recent advances AA Thai, BJ Solomon Current opinion in oncology 30 (2), 84-91, 2018 | 37 | 2018 |
| Identification of an excellent prognosis subset of human papillomavirus-associated oropharyngeal cancer patients by quantification of intratumoral CD103+ immune cell abundance B Solomon, RJ Young, M Bressel, J Cernelc, P Savas, H Liu, D Urban, ... Annals of Oncology 30 (10), 1638-1646, 2019 | 32 | 2019 |
| Validation and characterisation of prognostically significant PD-L1+ immune cells in HPV+ oropharyngeal squamous cell carcinoma RJ Young, M Bressel, S Porceddu, J Cernelc, P Savas, H Liu, D Urban, ... Oral Oncology 101, 104516, 2020 | 22 | 2020 |
| Hospital lung surgery volume and patient outcomes AA Thai, E Stuart, L Te Marvelde, RL Milne, S Knight, K Whitfield, ... Lung Cancer 129, 22-27, 2019 | 15 | 2019 |
| The utility of rapid on-site evaluation on endobronchial ultrasound guided transbronchial needle aspiration: does it make a difference? RWM Wong, A Thai, YH Khor, K Ireland-Jenkin, C J Lanteri, BR Jennings Journal of Respiratory Medicine 2014, 2014 | 15 | 2014 |
| Immunotherapy to avoid orbital exenteration in patients with cutaneous squamous cell carcinoma LS McLean, AM Lim, A Webb, K Cavanagh, A Thai, M Magarey, C Fox, ... Frontiers in Oncology 11, 796197, 2022 | 12 | 2022 |
| Exploring disparities in receipt of adjuvant chemotherapy in culturally and linguistically diverse groups: an Australian centre's experience AA Thai, M Tacey, A Byrne, S White, J Yoong Internal Medicine Journal 48 (5), 561-566, 2018 | 11 | 2018 |
| Co-design and development of online video resources about immunotherapy with patients and their family A Hyatt, B Morkunas, D Davey, AA Thai, M Trewhella, M Duffy, T Dawson, ... Patient education and counseling 104 (2), 290-297, 2021 | 10 | 2021 |
| 1279P Impact of KRAS mutations and subtypes on efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) J Mazieres, P Tomasini, A Lusque, M Boucekine, O Gautschi, AB Cortot, ... Annals of Oncology 31, S826-S827, 2020 | 10 | 2020 |
| Biology and treatment advances in cutaneous squamous cell carcinoma AA Thai, AM Lim, BJ Solomon, D Rischin Cancers 13 (22), 5645, 2021 | 8 | 2021 |
| MA04. 03 immunotherapy for non-small cell lung cancers (NSCLC) with oncogenic driver mutations: new results from the global IMMUNOTARGET registry O Gautschi, A Drilon, J Milia, A Lusque, L Mhanna, B Li, J Sabari, A Cortot, ... Journal of Thoracic Oncology 13 (10), S367, 2018 | 6 | 2018 |
| Targeting platelets for improved outcome in KRAS-driven lung adenocarcinoma SR Hyslop, M Alexander, AA Thai, A Kersbergen, AJ Kueh, MJ Herold, ... Oncogene 39 (29), 5177-5186, 2020 | 5 | 2020 |
| High-dose cisplatin for head and neck cancer lives on AA Thai, D Rischin Journal of Clinical Oncology 36 (11), 1055-1057, 2018 | 5 | 2018 |
| Comprehensive profiling identifies tumour and immune microenvironmental differences in clinical subsets of cutaneous squamous cell carcinoma AA Thai, RJ Young, M Bressel, C Angel, L McDowell, A Tiong, ... British Journal of Dermatology 189 (5), 588-602, 2023 | 3 | 2023 |
